Reawakening retrocyclins: ancestral human defensins active against HIV-1.
Ontology highlight
ABSTRACT: Human alpha and beta defensins contribute substantially to innate immune defenses against microbial and viral infections. Certain nonhuman primates also produce theta-defensins-18 residue cyclic peptides that act as HIV-1 entry inhibitors. Multiple human theta-defensin genes exist, but they harbor a premature termination codon that blocks translation. Consequently, the theta-defensins (retrocyclins) encoded within the human genome are not expressed as peptides. In vivo production of theta-defensins in rhesus macaques involves the post-translational ligation of two nonapeptides, each derived from a 12-residue "demidefensin" precursor. Neither the mechanism of this unique process nor its existence in human cells is known. To ascertain if human cells retained the ability to process demidefens
SUBMITTER: Venkataraman N
PROVIDER: S-EPMC2672613 | biostudies-literature | 2009 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA